One hundred and ninety-eight patients undergoing minor turgery were assessed for evidence of postsuxamethonium muscle pain on the 1 st and 2nd days following surgery. Patients were allocated to nine groups and were given one of four non-depolarizing neuromuscular blocking drugs (vecuronium, gallamine, tubocurarine or pancuronium) 1 or 2 min before the administration of suxamethonium. A control group received an inert medication. Forty-one per cent of patients receiving no pretreatment experienced muscle pain. This frequency was decreased to around 20% following pretreatment. In general, the frequency of pain was less in the groups receiving pretreatment at 1 min, but the difference was not significant. The groups receiving vecuronium before suxamethonium had the lowest overall frequency of pain over the 2 days (19%), although this was not significantly different from other p re treatments.
The frequency of muscle pain following the administration of suxamethonium has been variously reported as being between 85% (Foster, 1960) and 4.5% (Pearcey and Pick, 1960) . Several factors have been described as having an influence on this phenomenon, including the choice and use of induction agent (Burtles, 1961; Craig, 1964) , the patient's age (Bush and Roth, 1961) and sex (Leatherdale, Mayhew and Hayton-Williams, 1959 ) and the time of ambulation following surgery (ChurchillDavidson, 1954) . Although various means of decreasing the frequency of pain have been described, the use of small doses of competitive neuromuscular blocking drugs, preceding the administration of suxamethonium, remains the most widely accepted means of prophylaxis (Churchill-Davidson, 1954; Morris and Dunn, 1957; Foster, 1960) .
Vecuronium (Org NC45) is a new nondepolarizing neuromuscular blocking drug. Apart from the desirable attributes of cardiovascular stability and short duration of action, the drug has been reported to act more rapidly than other nondepolarizing drugs, particularly with regard to intubating conditions (Agoston et al., 1980; Mirakhur et al., 1983) . This property of the drug may be relevant to its use in prophylaxis against postsuxamethonium muscle pain as other neuromuscular blockers may require up to 3 min for maximal effectiveness (Burtles and Tunstall, 1961; White, 1962) .
PATIENTS AND METHODS
One hundred and ninety-eight patients (ASA grade I) aged between 15 and 70 yr, scheduled for minor elective surgery requiring the use of suxamethonium and tracheal intubation, were included in the study. The study was approved by the Regional Ethics Committee. Premedication was avoided or restricted to atropine where this was felt necessary. Patients were allocated randomly to nine groups, with at least 20 patients in each group. Pretreatment consisted of vecuronium 1 mg, gallamine 20 mg, pancuronium 1 mg or tubocurarine 5mg, doses which are approximately equipotent, given either 1 min or 2 min before the administration of the suxamethonium.
Anaesthesia was induced with thiopentone 5mgkg"' given 30 s before the administration of the suxamethonium 1.5mgkg~' to facilitate tracheal intubation. Maintenance of anaesthesia was with nitrous oxide and halothane in oxygen, with spontaneous respiration after the effects of suxamethonium had worn off. Fasciculations were graded as absent, moderate or severe.
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The assessment of each patient for muscle pain was carried out on the 1st and 2nd days following operation by one author only who had no knowledge of the nature of the pretreatment. Assessment was standardized to avoid suggestive influences and an overall muscle pain rating of absent, moderate or severe arrived at for each day. Patients discharged before completing the assessment were visited at home.
In six patients from each group, serum potassium and creatinine phosphokinase (CPK) concentrations were measured, using the ion selective electrode (Technicon) and Sequential Multiple Analyser Computer Mark I (SMAC I) methods, respectively. Blood samples for these estimations were taken from an antecubital vein before the induction of anaesthesia, after pretreatment and 1, 2,4, 6 and 10 min following administration of suxamethonium.
A chi-squared test with Yates' Correction was applied to the frequency of pain for assessment of statistical significance, and the effects of pretreatment on potassium and CPK concentrations were analysed using a paired t test.
RESULTS
The nine groups were comparable with regard to age, weight and sex distribution (table I) .
In all, 54 patients (29%) had muscle pain in the pretreatment groups and 9 (41%) in the control group. These values were not significantly different. The frequency of pain on the 1st and 2nd days is shown in table II. Although more patients demonstrated pain on the 2nd day (20% of patients pretreated), in comparison with the 1st day (16% of patients pretreated), this difference was not significant. In the control group the frequency of pain was similar (41%) on both days. The frequency of pain over both days in all groups is shown in figure 1 . The lowest frequency of pain was found in the vecuronium 2-min group (18.5%). All the 1-min pretreatment groups had a frequency of 19-20% except the pancuronium group where the frequency was 25%. The frequencies of pain in the 2-min groups of pancuronium, gallamine and tubocurarine were 28, 30 and 30%, respectively. In general, the difference in the overall frequency of pain over the 2 days was not significantly different whether the pretreatment was administered 1 or 2 min before the suxamethonium.
Although all the pretreatment groups had considerably fewer patients with muscle pain than the control group, the difference was not significant nor were the differences amongst the pretreatment groups themselves. The frequency of muscle pain on the 1st day after operation was significantly less after vecuronium or gallamine than in the control group. The frequency on the 2nd day was also less than control after tubocurarine given 1 min or pancuronium or vecuronium given 2 min before the suxamethonium. Table II also shows the frequency of moderate and severe pain in all the groups (the mild pain which is least upsetting to the patients being disregarded). Pretreatment with vecuronium at 1 and 2 min and pancuronium at 1 min afforded a total protection from such pain on both days; the same was true for the gallamine and tubocurarine 1-min groups on the 1st day after surgery.
Although pretreatment significantly decreased the frequency of fasciculations in all groups (table III) , a comparison of the information in this table with that in table II and figure 1 shows that there was no correlation between the frequency of fasciculations and that of pain.
Serum potassium (K + ) and creatinine phosphokinase (CPK) concentrations were measured in six patients from each group. There were no significant changes in these in the control group and in only a few patients was a significant change detected in any of the pretreatment groups (tables IV and V). DISCUSSION A striking feature of the literature on muscle pain associated with suxamethonium is the wide range of frequency described. Pearcey and Pick (1960) reported that only 4.5% of patients in a series of 246 had pain, which contrasts dramatically with the 85% reported by Foster (1960) been mentioned in the introduction. While it is possible to confine the study more narrowly to rule out some of these influences, we felt it was more important to place it firmly in everyday clinical practice. Although the administration of nondepolarizing drugs for pretreatment on a weightrelated basis has been recommended (Wig and Bali, 1979) , as has the use of a fixed-dose routine (Morris and Dunn, 1957; Bennetts and Khalil, 1981) , we used the latter method for ease of routine administration. Churchill-Davidson (1954) obtained a significant decrease in pain with gallamine 40 mg, but Konchigeri and Tummuru (1979) and Foster (1960) obtained good results with 20 mg, so the smaller dose was chosen for this study. Bennetts and Khalil (1981) used tubocurarine 5mg and, as this is the dose used routinely by our colleagues, it was decided that it would be suitable for this study. Pancuronium was found by Wig and Bah ' (1979) to be effective in a dose of 0.01 and 0.02 mg kg"'. This can be approximately related to a standard 1 mg for the average adult and this has been used previously by Konchigeri and Tummuru (1979) and Bennetts and Khalil (1981) . Vecuronium is regarded as being approximately equipotent with pancuronium (Agoston et al., 1980) and was also administered in 1-mg doses.
The time interval between administration of the pretreatment and the suxamethonium has been regarded as important (White, 1962) . While some authors considered an interval of 1 min adequate (Collier, 1975) others have recommended 2, 3 and 4 min or even longer (White, 1962; Stoelting and Peterson, 1975; Brodsky, Brock-Utne and Samuels, 1979; Erkola, Salmenpera and Tammisto, 1980) . Obviously, the time interval should be as short as possible to allow a busy operating schedule to proceed smoothly, and yet it must be long enough to allow sufficient effect. Intervals of 1 and 2 min were chosen in the present study in the hope that the reputed faster onset of action of vecuronium could permit a decrease in the time interval required between pretreatment and the administration of suxamethonium. The results show that, of all the agents studied, vecuronium at 1 or 2 min was the best, although the difference was not statistically significant.
In concurrence with previously published studies (Newman and Loudon, 1960; Cooke et al., 1963; Bennett et al., 1973) it was concluded that, although pretreatment significantly decreased the frequency of fasciculations, their severity had no correlation with the frequency of pain.
Pretreatment with competitive neuromuscular blockers antagonizes the neuromuscular blockade induced by suxamethonium, and to overcome this effect Cullen (1971) recommended increasing the dose of suxamethonium. Stoelting and Peterson (1975) stated that the larger suxamethomum dose was not associated with any accentuation of its adverse effects. In the light of this suggestion and our own clinical experience we decided to give suxamethonium in a dose of 1.5 mg kg "'.
The speed of postoperative ambulation has been described as a factor increasing the frequency of pain (Churchill-Davidson, 1954) . Although no attempt was made in this study to assess the influence of this, the vast majority of patients underwent minor dental, ENT or eye surgery and were fully ambulant on the day following operation. We would agree with Bennetts and Khalil (1981) that there is little difference between today's minor inpatient and an outpatient when considering their postoperative activity, so that a distinction between the groups is unimportant.
The failure to demonstrate significant increases in K + and CPK concentrations or differences between the groups, is not altogether surprising. The fact that suxamethonium causes the release of K + in certain conditions (for example thermal injury patients, certain neurological disorders) is well known and is thought to result from an increased chemosensitivity of the muscle membrane, as a result of the development of extrajunctional receptor sites in these patients (Gronert and Theye, 1978) . Suxamethonium induces a small release of K + in normal muscle, but this may be difficult to detect when small numbers of patients are being studied. There is some controversy as to whether pretreatment has an effect on K + and CPK concentrations following suxamethonium. Stoelting and Peterson (1975) found that increases in K + and CPK concentration were similar in pretreatment and control groups while Weintraub, Heisterkamp and Cooperman (1969) reported that pretreatment with tubocurarine would halve the increase in K + concentration caused by suxamethonium. This last view is supported by Strieker and Morrow (1968) , who reported a significant increase in K + concentration following suxamethonium, which was absent in patients pretreated with tubocurarine.
In conclusion the present study showed that vecuronium was slightly more effective than other nondepolarizing neuromuscular blocking drugs in decreasing the frequency of post-suxamethonium muscle pain-when administered 1 or 2 min before the suxamethonium. The differences, however, were not statistically significant when compared to other commonly used pretreatment regimens. 
